Premium
Molecular markers in renal cell carcinoma
Author(s) -
Thrasher J. Brantley
Publication year - 1999
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19991201)86:11<2195::aid-cncr3>3.0.co;2-m
Subject(s) - medicine , renal cell carcinoma , clinical trial , oncology , antibody , pathology , immunology
Molecular markers are becoming an increasingly important tool for diagnosing, staging, predicting recurrences of, and directing the treatment of multiple malignancies. However, variable techniques, variable antibodies, interobserver variability in the assessment of the markers, cost, and the lack of multi‐institutional trials have limited the use of these markers in clinical practice. See also pages 2320–6.